Austria leads global government expenditures on R&D in health with a value of 5.56. The Netherlands, Norway, and Switzerland follow closely, each with values above 4.5. In contrast, Japan and Israel stand at the lower end with minimal expenditures. The data highlights a varied commitment across countries to health R&D funding, revealing a concentrated higher investment in European nations, except Japan and Israel, which are exceptions in Asia.
Future trends to watch include potential growth in health R&D funding in response to global health challenges. Countries with lower current investments might increase their budgets to enhance healthcare innovation and respond to emerging health needs. Watch for fluctuations based on economic shifts or health sector demands globally.
Top countries in Government Expenditures on R&D Health by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Austria | 5.56 | 2023 | View data |
| 2 | 2 Netherlands | 4.88 | 2023 | View data |
| 3 | 3 Norway | 4.78 | 2023 | View data |
| 4 | 4 Switzerland | 4.75 | 2023 | View data |
| 5 | 5 Spain | 4.23 | 2023 | View data |
| 6 | 6 Portugal | 3.89 | 2023 | View data |
| 7 | 7 Estonia | 3.68 | 2023 | View data |
| 8 | 8 Luxembourg | 3.43 | 2023 | View data |
| 9 | 9 Australia | 3.09 | 2023 | View data |
| 10 | 10 Greece | 2.86 | 2023 | View data |
